REGULATORY

• Master Plan on COVID-19 Measures to Be Compiled Relatively Soon: Response Minister
  October 6, 2021

• New Vaccine Czar Hints Booster Program Could Start in December
  October 6, 2021

• Transparency and Predictability Up for Discussion towards 2022 Drug Pricing Reform: New Minister
  October 6, 2021

• PM Kishida Orders 3 Ministers to Map Out Overall COVID-19 Response Plan
  October 5, 2021

• Innovative Drug Makers Log Sluggish Generic Use Rates: MHLW Data
  October 5, 2021

• New Health Minister Goto Vows to Protect Secure Healthcare System in FY2022 Reform
  October 5, 2021

• Nipocalimab, 3 Other APIs Earn Orphan Status in Japan
  October 5, 2021

• No Major Safety Concerns for Moderna, Pfizer COVID-19 Vaccines: MHLW Panels
  October 4, 2021

• Manabu Yoshida Becomes Vice Health Minister, Top Bureaucrat at MHLW
  October 4, 2021

• No Factor to Impede Reinstatement of HPV Vaccine Recommendation: Panels
  October 4, 2021

• Govt Must Prepare for Booster Shot Rollout before Year-End: Kono
  October 4, 2021

• Ex-PMDA Chief Kondo, Credited with Eliminating Japan’s Drug Lag, Dies at 79
  September 30, 2021

• Pharma Officials Air Hopes and Concerns for New LDP Leader, Eyes on MHLW Revamp
  September 30, 2021

• GSK’s COVID-19 Drug to Be Allocated through Govt for Now
  September 30, 2021

• MHLW Panel to Discuss HPV Vaccine Recommendation on Oct. 1
  September 29, 2021

• Veklury’s Normal Distribution in Japan to Start from Oct. 18
  September 29, 2021

• Reorganization of MHLW Inevitable: PM Suga
  September 29, 2021

• Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
  September 28, 2021

• MHLW to Further Push Single-Product, Single-Price Trades, Prohibit Dumping in Revised Distribution Guidelines
  September 28, 2021

• Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
  September 28, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• …
• Next ›
• 最終 »